Accès gratuit
Numéro
Med Sci (Paris)
Volume 19, Numéro 3, Mars 2003
Page(s) 377 - 380
Section Forum : Hypothèses/Débats
DOI https://doi.org/10.1051/medsci/2003193377
Publié en ligne 15 mars 2003
  1. The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker versus diuretic. The antihypertensive and lipid lowering treatment to prevent heart attack trial (ALLHAT). JAMA 2002; 288: 2998–3007.
  2. Appel LJ. The verdict from ALLHAT-thiazide diuretics are the preferred initial therapy for hypertension. JAMA 2002; 288: 3039–42.
  3. Williams RL, Blume CD, Lin ET, et al. Relative bioavailability of chlorthalidone in humans: adverse influence of polyethylene glycol. J Pharmacol Sci 1982; 71: 533–5.
  4. Beermann B, Groschinsky- Grind M. Pharmacokinetics of hydrochlorothiazide in man. Eur J Clin Pharmacol 1977; 12: 297–303.
  5. Psaty BM, Manolio TA, Smith NL, et al. Time trends in high blood pressure control and the use of antihypertensive medications in older adults. The Cardiovascular Health Study. Arch Intern Med 2002; 162: 2325–32.
  6. Fitzsimons JT. Angiotensin, thirst and sodium appetite. Physiol Rev 1998; 78: 583–686.
  7. Asmar R, Benetos A, London GM, et al. Aortic distensibility in normotensive, untreated and treated hypertensive patients. Blood Pressure 1995; 4 : 48–54.
  8. Plante GE, Bissonnette M, Sirois MG, et al. Renal permeability alteration precedes hypertension and involves bradykinin in the spontaneously hypertensive rat. J Clin Invest 1992; 89: 2030–4.
  9. Gibbons GH, Dzau VJ. The emerging concept of vascular remodeling. N Engl J Med 1994; 330: 1431–8.
  10. Lehoux S, Plante GE. Antihypertensive drugs and endothelial cell function. Prostaglandins Leukot Essent Fatty Acids 1996; 54: 65–70.
  11. Arnal JF, Battle T, Rasetti C, et al. ACE in three tunicae of rat aorta: expression in smooth muscle and effect of renovascular hypertension. Am J Physiol 1994; 267: H1777–84.
  12. Labat C, Lacolley P, Koffi I, et al. AT1 blockade of angiotensin II and sodium diet: effect on carotid artery structure and function in SHRs. J Hypertens 1999; 17: S131.
  13. Benetos A, Lafleche A, Asmar R, et al. Arterial stiffness, hydrochlorothiazide and converting enzyme inhibition in essential hypertension. J Hum Hypertens 1996; 10: 77–82.
  14. Girerd X, Chanudet X, Larroque P, et al. Early arterial modifications in young patients with borderline hypertension. J Hypertens 1989; 7: S456–7.
  15. Simonson E, Makagawa K. Effect of age on pulse wave velocity and aortic ejection time in healthy men and in men with coronary artery disease. Circulation 1960; 22: 126–9.
  16. London G, Guérin A, Pannier B, et al. Increased systolic pressure in chronic uremia: Role of arterial wave reflections. Hypertension 1992; 20 : 10–9.
  17. MacSweeney ST, Young G, Greenhalgh RM, et al. Mechanical properties of the aneurysmal aorta. Br J Surg 1992; 79: 1281–4.
  18. Brodeur C, Girard B, Plante GE. Incorporation du soufre marqué dans les protéoglycanes de la paroi aortique: effets d’agents diurétiques. Med Sci 1998; 14: S21.
  19. El Taouil K, Schiavi PI, Levy B, et al. Sodium intake, large artery matrix composition and compliance in the SHR. Hypertension 2001; 38: 1172–6.
  20. Wadworth AN, Murdoch D, Brogden RN. Atenolol: a reappraisal of its pharmacological properties and therapeutic use in cardiovascular disorders. Drugs 1991; 42: 468–510.
  21. Benfield P, Clissold SP, Brogden RN. Metoprolol. Drugs 1986; 31: 376–429

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.